This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kirpensteijn, J. Articles by Teske, E. Search for Related Content PubMed PubMed Citation Articles by Kirpensteijn, J. Articles by Teske, E.

Prognostic Significance of a New Histologic Grading System for Canine Osteosarcoma

Departments of Clinical Sciences of Companion Animals (JK, GRR, ET) and Pathology (MK), Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands

Histologic grade is an important determinant in clinical outcome of human osteosarcoma (OS). In this study, the histologic characteristics of primary and metastatic canine OS were evaluated using a new classification system. Histologic characteristics were classified in 166 primary and 34 metastatic canine OS. Prognostic variables for clinical outcome were determined using multivariate analysis. Most OS were histologically characterized by severe to extreme cellular pleomorphism, a variable number of mitoses, small to moderate amounts of matrix, a high percentage of tumor cells, and minimal to moderate amounts of necrosis. Tumor invasion into vessels was present in 117/152 (71%) tumors, and 12/50 (24%) of the regional lymph nodes had evidence of metastasis. Classification of the 166 tumors resulted in seven (4%) grade I, 34 (21%) grade II, and 125 (75%) grade III OS. In the multivariate analysis, histologic grade III OS and elevated pretreatment plasma alkaline phosphatase (AP) levels were independent predictors of clinical outcome. Dogs with high-grade tumors and elevated AP should be carefully evaluated for the presence of metastatic disease before starting adjunctive therapy protocols.

Key words: Dogs; grading system; osteosarcoma; prognosis.

Request reprints from Dr. J. Kirpensteijn, Department of Clinical Sciences of Companion Animals, Faculty of Veterinary Medicine, Utrecht University, PO Box 80.154, 3508 TD Utrecht (The Netherlands).

This article has been cited by other articles:

				R. Chun, L. D. Garrett, C. Henry, M. Wall, A. Smith, and N. M. Azene Toxicity and Efficacy of Cisplatin and Doxorubicin Combination Chemotherapy for the Treatment of Canine Osteosarcoma J. Am. Anim. Hosp. Assoc., November 1, 2005; 41(6): 382 - 387. [Abstract] [Full Text] [PDF]

				J. M. Liptak, W. S. Dernell, R. C. Straw, S. A. Rizzo, M. H. Lafferty, and S. J. Withrow Proximal Radial and Distal Humeral Osteosarcoma in 12 Dogs J. Am. Anim. Hosp. Assoc., November 1, 2004; 40(6): 461 - 467. [Abstract] [Full Text] [PDF]

				M. J. Hoenerhoff, M. Kiupel, D. Rosenstein, and R. R. Pool Multipotential Osteosarcoma with Various Mesenchymal Differentiations in a Young Dog Vet. Pathol., May 1, 2004; 41(3): 264 - 268. [Abstract] [Full Text] [PDF]

				P. Loukopoulos, B. A. Mungall, R. C. Straw, J. R. Thornton, and W. F. Robinson Matrix Metalloproteinase-2 and -9 Involvement in Canine Tumors Vet. Pathol., July 1, 2003; 40(4): 382 - 394. [Abstract] [Full Text] [PDF]